TRANS CA125 doubling

• Research type

  Research Study

• Full title

  Sample collection study to investigate the predictive role of hormone receptors and gene expression in relation to treatment with tamoxifen and the relationship to outcome by change in slope of CA125 in multiply-relapsed ovarian cancer patients participating in CA125 doubling trial

• IRAS ID

  146078

• Contact name

  Marcia Hall

• Contact email

  marcia.hall@nhs.net

• Sponsor organisation

  East and North Herts NHS Trust

• REC name

  Wales REC 4

• REC reference

  13/WA/0409

• Date of REC Opinion

  19 Dec 2013

• REC opinion

  Favourable Opinion